Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
Acupuncture combined with gradual benzodiazepine reduction for benzodiazepine-dependent Insomnia: A multicenter
Zhu-Qing Fan1, Yi-Song Gao1, Yu-Hong Chen1
1Department of Acupuncture-Moxibustion and Traditional Chinese Orthopedics, Fu Xing Hospital, Capital Medical University (FXH-CMU), Beijing 100038, China.
Background:
This study aimed to evaluate the clinical efficacy of acupuncture combined with gradual benzodiazepine dose reduction in patients with benzodiazepine-dependent insomnia (BDI) and to assess associated withdrawal outcomes.
Methods:
A total of 64 patients with BDI were randomly assigned to either the acupuncture plus gradual benzodiazepine reduction group (ARB, n = 32) or the placebo acupuncture plus gradual benzodiazepine reduction group (PARB, n = 32). Treatments were administered five times per week for 4 weeks, followed by an 8-week observation period. The primary outcomes were changes in Insomnia Severity Index (ISI) scores and the drug reduction rate of benzodiazepines (DRRB). Secondary outcomes included the rate of successful discontinuation and scores on the Fatigue Scale-14 (FS-14).
Results:
Sixty-three patients completed the trial (ARB group, n = 32; PARB group, n = 31). Patients in the ARB group demonstrated significantly greater reductions in ISI scores compared with those in the PARB group (p = 0.005 for week 4-week 0 and week 12-week 0 comparisons). The DRRB was also significantly higher in the ARB group compared with the PARB group (p = 0.002 for week 4-week 1 and p < 0.001 for week 12-week 1). At week 12, the ARB group additionally demonstrated lower FS-14 scores and a higher rate of successful benzodiazepine discontinuation.
Conclusions:
Acupuncture combined with gradual benzodiazepine reduction significantly reduced insomnia severity and promoted benzodiazepine discontinuation in patients with BDI.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Management of Insomnia
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

